Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/05/1998WO1998048824A1 Bioactive peptides derived from cocaine and amphetamine regulated transcript protein
11/05/1998WO1998048823A1 Anti-bacterial composition
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048821A2 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048813A1 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
11/05/1998WO1998048809A1 Use of immunomodulating agents
11/05/1998WO1998048799A1 Protease inhibitors
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048784A2 Method and composition for modulating amyloidosis
11/05/1998WO1998048779A1 Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
11/05/1998WO1998048775A1 Serine protease and topical retinoid compositions
11/05/1998WO1998048630A1 Method of treating malignancies
11/05/1998WO1998042737A3 Peptides for the treatment of systemic lupus erythematosus
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998037091A3 Modified retinoblastoma tumor suppressor proteins
11/05/1998WO1998034954A3 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
11/05/1998WO1998033920A3 Tissue factor pathway inhibitor-3
11/05/1998WO1998033527A3 Cancer immunotherapy with semi-allogeneic cells
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998WO1998031805A3 Human zinc binding proteins
11/05/1998WO1998031799A3 Polynucleotides and polypeptides encoding receptors
11/05/1998WO1998028331A3 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof
11/05/1998WO1998024904A3 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
11/05/1998DE19720162A1 Mittel zur Steigerung der Herzkraft Means of increasing the myocardial contractile force
11/05/1998DE19720154A1 Mittel zur Behandlung von Tumorerkrankungen durch Entfernen von B-Lymphozyten der Patienten Agents for the treatment of tumor diseases by removal of B-lymphocytes of patients
11/05/1998DE19718248A1 New nucleic acid encoding nCL-3 calpain
11/05/1998DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/05/1998CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2289109A1 Carbohydrate-deficient glycoprotein syndrome type i
11/05/1998CA2289040A1 Nerve growth factor as a vaccine adjuvant
11/05/1998CA2289019A1 Calcitonin receptor-binding peptides
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288433A1 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998CA2288351A1 Chimeric opg polypeptides
11/05/1998CA2288346A1 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998CA2288343A1 Secreted proteins and polynucleotides encoding them
11/05/1998CA2288332A1 (3r)-3-amino-4-carboxybutyraldehyde derivatives inhibiting the release of interleukin-1/beta
11/05/1998CA2288306A1 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998CA2288238A1 Leptin as an inhibitor of tumor cell proliferation
11/05/1998CA2288138A1 Compounds and compositions for delivering active agents
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287989A1 Protease inhibitors
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2287910A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways
11/05/1998CA2287877A1 Method of treating sepsis
11/05/1998CA2287876A1 Rat st38.2 chemokine
11/05/1998CA2287782A1 Human theta subunit of the gaba-a receptor
11/05/1998CA2287538A1 Truncated vegf-related proteins
11/05/1998CA2286861A1 Method for cleavage of fusion proteins
11/05/1998CA2286558A1 Ngf variants
11/05/1998CA2285983A1 Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
11/05/1998CA2285948A1 Method and composition for modulating amyloidosis
11/05/1998CA2285628A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
11/05/1998CA2280747A1 Serine protease and topical retinoid compositions
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/05/1998CA2258266A1 Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875564A1 Biologically active extract from the leech 'Limnatis nilotica'
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875253A2 Chondroitinase compositions
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0875251A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
11/04/1998EP0875249A1 Complexes consisting of FE(III), a polyhydroxylated compound, and ovalbumin
11/04/1998EP0874909A2 Long-term expression of gene products by transforming muscle cells
11/04/1998EP0874905A1 Novel tcts response regulator of staphylococcus aureus
11/04/1998EP0874904A1 Methods for delivering dna to muscle cells using recombinant adenoassociated virus virions
11/04/1998EP0874902A2 Compositions and methods for the treatment and diagnosis of breast cancer
11/04/1998EP0874900A1 Improved nucleic acids encoding a chimeric glycosyltransferase
11/04/1998EP0874864A1 Osteo antiviral protein
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874641A1 Method for effecting changes in the central nervous system by administration of igf-i or igf-ii
11/04/1998EP0874640A1 Cyclosporin formulation
11/04/1998EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998EP0874638A1 Hemoregulatory compounds
11/04/1998EP0874637A1 Therapeutic applications of t-bam (cd40l) technology to treat inflammatory kidney diseases
11/04/1998EP0874634A1 Control of healing process
11/04/1998EP0874624A2 Hyaluronic acid receptors binding agents and the use thereof
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0842194A4 Chimeric receptor molecules for delivery of co-stimulatory signals
11/04/1998EP0710104B1 Pharmaceutical compositions for hardly soluble active substances
11/04/1998EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
11/04/1998EP0656950B1 Tat-derived transport polypeptides
11/04/1998EP0602144B1 Dna sequences encoding gelonin polypeptide
11/04/1998EP0598034B1 Production of peptide amides
11/04/1998EP0554446B1 Monoclonal antibodies useful in therapy of HIV-1 infection
11/04/1998EP0486622B1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
11/04/1998CN1198214A Quantitation of P97 to diagnose and monitor Alzheimer's disease
11/04/1998CN1198185A Detection, prevention and treatment of papillomatous digital dermatitis
11/04/1998CN1198165A Modulators of function of FAS receptors and other proteins
11/04/1998CN1198098A Use of muteins of wild-type cytokines as immunogens
11/04/1998CN1198097A Stable extract of hypericum perforatum L., process for preparing the same and pharmaceutical compositions
1 ... 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 ... 3163